Sana Pharma Medical AS
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Sana Pharma Medical AS - overview
Established
2014
Location
-, -, Norway
Primary Industry
Pharmaceuticals
About
Based in Lysaker, Norway, and founded in 2014, Sana Pharma Medical a medical company that develops produces, and distributes human medicinal products across pharmacies in several North European markets with local offices in Norway, Sweden, Finland, and Denmark. In July 2021, the company was acquired by Mallax Pharmaceuticals AB. The firm offers products related to women’s health, sleep, anxiety, and cough & cold brands such as Lunixen and Sedix and other products based on the substance melatonin. Through the investment of Mallax Pharmaceuticals, both companies will create a new platform for pharmaceutical and healthcare products in the Nordics.
Current Investors
Mallax Pharmaceuticals AB
Primary Industry
Pharmaceuticals
Sub Industries
Consumer Products, Healthcare, Pharmaceuticals
Website
www.sanapharma.no
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Sana Pharma Medical AS - timeline of key events
Sana Pharma Medical AS - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 171,702 | - | - | - | 2,203,047 | 13,810,313 | 28,172,984 | 30,362,727 | 39,234,605 | 56,049,835 | 63,534,203 | - | - | - |
| % Revenue Growth (YoY) | - | (100.0%) | - | - | - | 526.9% | 104.0% | 7.8% | 29.2% | 42.9% | 13.4% | - | - | - |
| EBITDA (USD) | (4,360,332) | (658,326) | (80,970) | (1,384,162) | (10,042,369) | (9,411,779) | (2,661,446) | (2,019,859) | (955,319) | 2,077,883 | 6,017,638 | - | - | - |
| Operating Income (USD) | (4,360,332) | (658,326) | (80,970) | (1,384,162) | (10,042,369) | (9,411,779) | (2,661,446) | (2,019,859) | (955,319) | 2,077,883 | 5,545,639 | - | - | - |
| Operating Margin | (2539.5%) | - | - | - | (455.8%) | (68.2%) | (9.4%) | (6.7%) | (2.4%) | 3.7% | 8.7% | - | - | - |
| % EBITDA Margin | (2539.5%) | - | - | - | (455.8%) | (68.2%) | (9.4%) | (6.7%) | (2.4%) | 3.7% | 9.5% | - | - | - |
| NET Income (USD) | (4,143,576) | (523,541) | 3,654,463 | 5,662,550 | (20,982,977) | (8,078,072) | (2,819,781) | (2,048,956) | (1,407,532) | 1,839,221 | 2,271,079 | - | - | - |
| % Net Margin | (2413.2%) | - | - | - | (952.5%) | (58.5%) | (10.0%) | (6.7%) | (3.6%) | 3.3% | 3.6% | - | - | - |
Sana Pharma Medical AS - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Sana Pharma Medical AS | - |
Displaying 1 - 1 of 1
Sana Pharma Medical AS - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.